6-K ·Filed Apr 8, 2026
Notable filing: 6-K
Actionable Insight • Neutral
This is a standard corporate governance update with no immediate financial impact. The appointments are focused on strengthening board expertise in clinical leadership and financial oversight as Telix evolves into a dual-listed, global, commercial-stage biopharmaceutical company.
Final — all horizons settled through T+60d ⚠ clustered
TLPPF ▲ +26.80% at T+60d
NEUTRAL call +26.80% · α vs SPY +16.02% · entry $9.70 → $12.30
T+1d
0.00%
call 0.00% · α +0.06%
$9.70
settled 7mo ago
T+5d
+10.10%
call +10.10% · α +6.92%
$10.68
settled 7mo ago
T+20d
+14.02%
call +14.02% · α +6.45%
$11.06
settled 6mo ago
T+60d
+26.80%
call +26.80% · α +16.02%
$12.30
settled 4mo ago
Price Chart
Loading chart...
Executive Summary
Telix Pharmaceuticals announced the appointment of two new non-executive directors, Maria Rivas and William Jellison, to strengthen its board. This is a routine corporate governance update with no material financial implications.
Key Facts
- Telix Pharmaceuticals announced the appointment of two new non-executive directors, Maria Rivas and William Jellison
- The appointments are effective May 11, 2026
- The appointments are part of board expansion and succession planning
Financial Impact
None disclosed
Risk Factors
- None disclosed
Market Snapshot
Exchange
OTC
Sector
Pharmaceutical Preparations
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001628280-26-024320 |
| Document: a20260409nedappointments.htm | 0001628280-26-024320 |
| Document: 0001628280-26-024320-index-headers.html | 0001628280-26-024320 |
| Document: 0001628280-26-024320-index.html | 0001628280-26-024320 |
| Document: 0001628280-26-024320.txt | 0001628280-26-024320 |
10 reports for TLPPF
100% Hit rate @ T+60 Went positive at some point 4 of 4 best @ T+60▲ +31.94%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
May 21, 2026 22w ago | 6-K | $9.75 $11.50 | ▲ +17.95% | ▲ +14.76% | $8.82 (−9.54%) |
May 18, 2026 23w ago | 3 | $9.75 $11.69 | ▲ +19.94% | ▲ +13.65% | $8.82 (−9.54%) |
May 18, 2026 23w ago | 3 | $9.75 $11.69 | ▲ +19.94% | ▲ +13.65% | $8.82 (−9.54%) |
May 18, 2026 23w ago | 3 | $9.75 $11.69 | ▲ +19.94% | ▲ +13.65% | $8.82 (−9.54%) |
Apr 21, 2026 27w ago | 6-K | $10.50 $10.50 | · 0.00% | ▼ −4.78% | $8.82 (−16.00%) |
Apr 14, 2026 28w ago | 6-K | $10.57 $11.50 | ▲ +8.80% | ▲ +0.28% | $8.82 (−16.56%) |
Apr 13, 2026 28w ago | 6-K | $10.57 $11.50 | ▲ +8.80% | ▲ +0.28% | $8.82 (−16.56%) |
Apr 9, 2026 28w ago | 6-K | $9.70 $11.45 | ▲ +18.04% | ▲ +7.71% | $8.82 (−9.08%) |
Apr 8, 2026 28w ago | 6-K | $9.70 $12.30 | ▲ +26.80% | ▲ +16.02% | $8.82 (−9.08%) |
Apr 7, 2026 29w ago | 6-K | $9.00 $11.88 | ▲ +31.94% | ▲ +18.67% | $8.82 (−2.01%) |
Showing 10 of 10
US Market Status
Market Closed — Opens in 8h 52m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers